Evidence map›Paper›PMID 10952677›Full record

ArticleBritish journal of pharmacology2000

Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro.

A Bischoff, P Czyborra, C Fetscher, D Meyer Zu Heringdorf, K H Jakobs, M C Michel

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Sphingolipids and Chronic Kidney Disease.Journal of clinical medicine · 2024
    Review
  3. Article
  4. Sphingosine-1-Phosphate Enhances αInternational journal of molecular sciences · 2019
    Article
  5. The Functional Requirement for CD69 in Establishment of Resident Memory CD8Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis.The Journal of pharmacology and experimental therapeutics · 2016
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Signaling pathway of lysophosphatidic Acid-induced contraction in feline esophageal smooth muscle cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2013
    Article
  17. Article
  18. Review
  19. Role of sphingosine-1-phosphate in the renal medulla.American journal of physiology. Renal physiology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A BischoffDepartment of Medicine, University of Essen, 45122 Essen, Germany. angela.bischoff@uni-essen.de
P Czyborra
C Fetscher
D Meyer Zu Heringdorf
K H Jakobs
M C Michel
University of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingolipids such as sphingosine-1-phosphate (SPP) and sphingosylphosphorylcholine (SPPC) can act both intracellularly and at G-protein-coupled receptors, some of which were cloned and designated as Edg-receptors. Sphingolipid-induced vascular effects were determined in isolated rat mesenteric and intrarenal microvessels. Additionally, sphingolipid-induced elevations in intracellular Ca(2+) concentration were measured in cultured rat aortic smooth muscle cells. SPPC and SPP (0.1-100 micromol l(-1)) caused concentration-dependent contraction of mesenteric and intrarenal microvessels (e.g. SPPC in mesenteric microvessels pEC(50) 5.63+/-0.17 and E(max) 49+/-3% of noradrenaline), with other sphingolipids being less active. The vasoconstrictor effect of SPPC in mesenteric microvessels was stereospecific (pEC(50) D-erythro-SPPC 5.69+/-0.08, L-threo-SPPC 5.31+/-0.06) and inhibited by pretreatment with pertussis toxin (E(max) from 44+/-5 to 19+/-4%), by chelation of extracellular Ca(2+) with EGTA and by nitrendipine (E(max) from 40+/-6 to 6+/-1 and 29+/-6%, respectively). Mechanical endothelial denudation or NO synthase inhibition did not alter the SPPC effects, while indomethacin reduced them (E(max) from 87+/-3 to 70+/-4%). SPP and SPPC caused transient increases in intracellular Ca(2+) concentrations in rat aortic smooth muscle cells in a pertussis toxin-sensitive manner. Our data demonstrate that SPP and SPPC cause vasoconstriction of isolated rat microvessels and increase intracellular Ca(2+) concentrations in cultured rat aortic smooth muscle cells. These effects appear to occur via receptors coupled to pertussis toxin-sensitive G-proteins. This is the first demonstration of effects of SPP and SPPC on vascular tone and suggests that sphingolipids may be an hitherto unrecognized class of endogenous regulators of vascular tone.

Indexed as

LysophospholipidsAnimalsCalciumDose-Response Relationship, DrugEgtazic AcidIndomethacinIn Vitro TechniquesMaleMesenteric ArteriesNitrendipineNitroargininePertussis ToxinPhosphorylcholinePsychosineRatsRats, WistarCalciumEgtazic AcidIndomethacinLysophospholipidsNitrendipineNitroargininePertussis ToxinPhosphorylcholinePsychosineSphingosinesphingosine 1-phosphatesphingosine phosphorylcholinesphingosyl beta-glucosideVasodilator AgentsVirulence Factors, Bordetella

Identifiers

PMID10952677
PMCPMC1572273
OpenAlexW1997240030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.